STENABOLIC (SR9009) SARM IN TABLETS

Stenabolic (SR-9009) — research compound

Stenabolic (SR-9009) is a Rev-ErbA agonist studied for its effects on circadian and metabolic pathways — a mechanism quite separate from the SARMs it is usually grouped with, which is why researchers treat it as a metabolic tool rather than an anabolic one. HelixaMed supplies SR-9009 independently assayed for identity and concentration so a study starts from verified material.

As with the other non-SARM research compounds in this range, the market is full of underdosed and mislabelled product, so third-party testing is essential — a certificate of analysis confirms the capsule matches its label. Its non-hormonal profile means different considerations from the receptor-modulating SARMs, set out on the product page. Sold strictly for research use; no dosing or human-use guidance is provided.

• Metabolic mechanism: a Rev-ErbA agonist of research interest.
• Verified: lab-checked identity and concentration.
• Non-hormonal: distinct from the SARM class.